Literature DB >> 21216803

Practical methods for competing risks data: a review.

Giorgos Bakoyannis1, Giota Touloumi.   

Abstract

Competing risks data arise naturally in medical research, when subjects under study are at risk of more than one mutually exclusive event such as death from different causes. The competing risks framework also includes settings where different possible events are not mutually exclusive but the interest lies on the first occurring event. For example, in HIV studies where seropositive subjects are receiving highly active antiretroviral therapy (HAART), treatment interruption and switching to a new HAART regimen act as competing risks for the first major change in HAART. This article introduces competing risks data and critically reviews the widely used statistical methods for estimation and modelling of the basic (estimable) quantities of interest. We discuss the increasingly popular Fine and Gray model for subdistribution hazard of interest, which can be readily fitted using standard software under the assumption of administrative censoring. We present a simulation study, which explores the robustness of inference for the subdistribution hazard to the assumption of administrative censoring. This shows a range of scenarios within which the strictly incorrect assumption of administrative censoring has a relatively small effect on parameter estimates and confidence interval coverage. The methods are illustrated using data from HIV-1 seropositive patients from the collaborative multicentre study CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe).

Entities:  

Mesh:

Year:  2011        PMID: 21216803     DOI: 10.1177/0962280210394479

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  39 in total

Review 1.  Applying competing risks regression models: an overview.

Authors:  Bernhard Haller; Georg Schmidt; Kurt Ulm
Journal:  Lifetime Data Anal       Date:  2012-09-26       Impact factor: 1.588

2.  Importance of the lipid-related pathways in the association between statins, mortality, and cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Denis Talbot; Joseph A Chris Delaney; Veit Sandfort; David M Herrington; Robyn L McClelland
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-06       Impact factor: 2.890

3.  Survival analysis in the presence of competing risks.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2017-02

4.  Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States.

Authors:  Cristina M Arce; Benjamin A Goldstein; Aya A Mitani; Colin R Lenihan; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

5.  The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF).

Authors:  Norihiko Kotooka; Masafumi Kitakaze; Kengo Nagashima; Machiko Asaka; Yoshiharu Kinugasa; Kotaro Nochioka; Atsushi Mizuno; Daisuke Nagatomo; Daigo Mine; Yoko Yamada; Akiko Kuratomi; Norihiro Okada; Daisuke Fujimatsu; So Kuwahata; Shigeru Toyoda; Shin-Ichi Hirotani; Takahiro Komori; Kazuo Eguchi; Kazuomi Kario; Takayuki Inomata; Kaoru Sugi; Kazuhiro Yamamoto; Hiroyuki Tsutsui; Tohru Masuyama; Hiroaki Shimokawa; Shin-Ichi Momomura; Yoshihiko Seino; Yasunori Sato; Teruo Inoue; Koichi Node
Journal:  Heart Vessels       Date:  2018-02-15       Impact factor: 2.037

6.  A pseudo-likelihood method for estimating misclassification probabilities in competing-risks settings when true-event data are partially observed.

Authors:  Philani B Mpofu; Giorgos Bakoyannis; Constantin T Yiannoutsos; Ann W Mwangi; Margaret Mburu
Journal:  Biom J       Date:  2020-06-10       Impact factor: 2.207

7.  Semiparametric competing risks regression under interval censoring using the R package intccr.

Authors:  Jun Park; Giorgos Bakoyannis; Constantin T Yiannoutsos
Journal:  Comput Methods Programs Biomed       Date:  2019-03-08       Impact factor: 5.428

8.  Nonparametric tests for transition probabilities in nonhomogeneous Markov processes.

Authors:  Giorgos Bakoyannis
Journal:  J Nonparametr Stat       Date:  2019-12-19       Impact factor: 1.231

9.  Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.

Authors:  Meredith S Shiels; Todd Gibson; Joshua Sampson; Demetrius Albanes; Gabriella Andreotti; Laura Beane Freeman; Amy Berrington de Gonzalez; Neil Caporaso; Rochelle E Curtis; Joanne Elena; Neal D Freedman; Kim Robien; Amanda Black; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

10.  Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.

Authors:  Courtney M Rowan; Francis Pike; Kenneth R Cooke; Robert Krance; Paul A Carpenter; Christine Duncan; David A Jacobsohn; Catherine M Bollard; Conrad Russell Y Cruz; Abhijeet Malatpure; Sherif S Farag; Jamie Renbarger; Hao Liu; Giorgos Bakoyannis; Samir Hanash; Sophie Paczesny
Journal:  Blood       Date:  2020-04-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.